Hypertension,Essential Clinical Trial
Official title:
A Multicenter, Prospective, Observational Study to Evaluate Effectiveness and Safety of Fixed-dose Combinations of Fimasartan/Amlodipine or Fimasartan/Amlodipine/Hydrochlorothiazide in Essential Hypertensive Patients
The main purpose of this observation study is to collect data on the effects and side effects for 12 weeks of the medication administration of the single-pill combinations, which are fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide, based on fimasartan. (Stage 1). Also, this study will evaluate major cardiovascular events, long-term blood pressure control, and the safety by follow-up of those who consent to the extended study for about 2 years (96 weeks).(Stage 2)
This study will be conducted as a prospective observational study in about 600 domestic medical institutions, which are at least clinical level. The investigator will enroll those who have essential hypertension and meet the inclusion and exclusion criteria after obtaining voluntary written consent for participation in the study and use of personal information. This study is a non-interventional observational study and is based on decisions by the investigator about the choice of antihypertensive drugs, the period of treatment, and the medication change status etc. During this study period, the scope of data to be collected is as follows: - Demographic information - Disease information (historical diseases and concomitant diseases ) - Physical measurements and vital signs - Blood pressure Central Blood pressure and hemodynamic values (if applicable) - Information on antihypertensive drugs and other concomitant medications - Adverse drug reaction(ADR) and serious adverse drug reactions(SADR) related to fimasartan/amlodipine or fimasartan/amlodipine/hydrochlorothiazide - Information on cardiovascular events (Only if subjects are in long term follow-up) - Death information (Only if subjects are in long term follow-up) ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05546931 -
Mobile Health Program for Rural Hypertension
|
N/A | |
| Completed |
NCT05086549 -
An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
|
||
| Recruiting |
NCT05086523 -
Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03503773 -
The TARGET BP OFF-MED Trial
|
Phase 2 | |
| Not yet recruiting |
NCT04082091 -
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
|
||
| Recruiting |
NCT06019598 -
Licorice and Home Blood Pressure, Additional Study
|
N/A | |
| Completed |
NCT04495231 -
Sympathetic Activity and Cardiometabolic Complications
|
||
| Completed |
NCT04119999 -
A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling
|
N/A | |
| Recruiting |
NCT04505618 -
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
|
N/A | |
| Recruiting |
NCT04863508 -
Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
|
||
| Completed |
NCT05185297 -
Recreational Futsal for Controlled Hypertension
|
N/A | |
| Completed |
NCT03855605 -
Diagnosis of Hypertension by Home Blood Pressure Monitoring
|
||
| Completed |
NCT03901183 -
Plant-based Nutrition for Patients With Cardiovascular Risk Factors
|
N/A | |
| Recruiting |
NCT06348576 -
Phase III Study to Evaluate the Efficacy and Safety of AD-209
|
Phase 3 | |
| Recruiting |
NCT03206814 -
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
|
N/A | |
| Recruiting |
NCT06343246 -
Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension
|
N/A | |
| Completed |
NCT06359873 -
Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension
|
||
| Recruiting |
NCT04565548 -
Hypertension Treatment Adherence Improving Trial
|
N/A | |
| Recruiting |
NCT06205628 -
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
|
Phase 1 | |
| Recruiting |
NCT04613193 -
Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis
|
N/A |